The following are the full annotation and the short annotation (used for network visualisation) assigned to this Mass2Motif.
Annotation: 4-Methyl-6-oxo-6H-benzo[c]chromen-3-yl substructure
Short Annotation: 4-Methyl-6-oxo-6H-benzo[c]chromen-3-yl substructure
The following table shows the fragment and loss features that are explained by this Mass2Motifs and their corresponding probabilities. After thresholding to save the model, the total probability left in this motif is 1.0. The column MAGMa Substructure Annotation shows substructures and the counts of MAGMa annotations for documents linked above threshold to this motif in this experiment. Hovering over each MAGMa substructure shows a plot of the substructure.
| Term name | Count in motif | Percentage in motif | Percentage in experiment | Absolute difference |
|---|---|---|---|---|
| Organic oxygen compound | 43 | 91.5 | 69.8 | 21.7 |
| Hydrocarbon derivative | 43 | 91.5 | 78.1 | 13.4 |
| Organooxygen compound | 43 | 91.5 | 68.4 | 23.1 |
| Organic oxide | 39 | 83.0 | 62.0 | 21.0 |
| Organoheterocyclic compound | 33 | 70.2 | 38.0 | 32.2 |
| Aromatic heteropolycyclic compound | 33 | 70.2 | 40.3 | 29.9 |
| Heteroaromatic compound | 33 | 70.2 | 36.8 | 33.4 |
| Benzenoid | 32 | 68.1 | 45.0 | 23.1 |
| Oxacycle | 29 | 61.7 | 27.5 | 34.2 |
| Benzopyran | 28 | 59.6 | 10.7 | 48.8 |
| Pyranone | 28 | 59.6 | 10.1 | 49.5 |
| Pyran | 28 | 59.6 | 10.7 | 48.9 |
| 1-benzopyran | 28 | 59.6 | 10.7 | 48.9 |
| Alkyl aryl ether | 27 | 57.4 | 24.7 | 32.7 |
| Ether | 27 | 57.4 | 30.9 | 26.5 |
| Monocyclic benzene moiety | 23 | 48.9 | 26.6 | 22.3 |
| Organic nitrogen compound | 23 | 48.9 | 60.8 | 11.9 |
| Organonitrogen compound | 23 | 48.9 | 60.8 | 11.8 |
| Organopnictogen compound | 19 | 40.4 | 46.6 | 6.2 |
| Monocarboxylic acid or derivatives | 17 | 36.2 | 19.7 | 16.5 |
| Carbonyl group | 17 | 36.2 | 41.3 | 5.1 |
| Carboxylic acid derivative | 17 | 36.2 | 35.2 | 1.0 |
| Carboxylic acid | 16 | 34.0 | 13.3 | 20.8 |
| Carboxamide group | 15 | 31.9 | 24.1 | 7.8 |
| Lactone | 15 | 31.9 | 12.7 | 19.2 |
| Azacycle | 14 | 29.8 | 46.4 | 16.6 |
| Coumarin | 14 | 29.8 | 5.6 | 24.2 |
| Chromone | 13 | 27.7 | 3.1 | 24.5 |
| 1-hydroxy-2-unsubstituted benzenoid | 12 | 25.5 | 8.9 | 16.7 |
| Anisole | 11 | 23.4 | 13.4 | 10.0 |
| Secondary carboxylic acid amide | 11 | 23.4 | 15.3 | 8.1 |
| Phenol ether | 9 | 19.1 | 13.0 | 6.2 |
| Phenol | 8 | 17.0 | 6.8 | 10.2 |
| 2-benzopyran | 8 | 17.0 | 0.7 | 16.3 |
| Isocoumarin | 8 | 17.0 | 0.6 | 16.5 |
| Flavone | 7 | 14.9 | 1.3 | 13.6 |
| N-acyl-alpha-amino acid | 7 | 14.9 | 4.4 | 10.5 |
| N-acyl-alpha amino acid or derivatives | 7 | 14.9 | 6.4 | 8.5 |
| Methoxybenzene | 6 | 12.8 | 7.9 | 4.9 |
| Phenoxy compound | 6 | 12.8 | 11.4 | 1.4 |
| Amine | 5 | 10.6 | 25.0 | 14.4 |
| Isoflavone | 5 | 10.6 | 0.4 | 10.3 |
| 4-phenylcoumarin | 5 | 10.6 | 0.7 | 10.0 |
| Alpha-amino acid or derivatives | 5 | 10.6 | 9.6 | 1.0 |
| 3-alkylindole | 5 | 10.6 | 4.9 | 5.8 |
| Substituted pyrrole | 5 | 10.6 | 3.9 | 6.8 |
| Pyrrole | 5 | 10.6 | 7.6 | 3.0 |
| Indole | 5 | 10.6 | 6.9 | 3.8 |
| 1-hydroxy-4-unsubstituted benzenoid | 4 | 8.5 | 5.3 | 3.2 |
| Tertiary carboxylic acid amide | 4 | 8.5 | 12.0 | 3.4 |
| Benzoyl | 4 | 8.5 | 7.2 | 1.3 |
| Benzoic acid or derivatives | 4 | 8.5 | 3.3 | 5.2 |
| Azole | 4 | 8.5 | 8.1 | 0.4 |
| Biphenyl | 4 | 8.5 | 0.7 | 7.9 |
| Secondary alcohol | 3 | 6.4 | 14.3 | 7.9 |
| Alcohol | 3 | 6.4 | 18.9 | 12.6 |
| Hydroxyflavonoid | 3 | 6.4 | 1.9 | 4.5 |
| Piperidine | 3 | 6.4 | 9.4 | 3.0 |
| 3-phenylpropanoic-acid | 3 | 6.4 | 1.4 | 4.9 |
| Phenylalanine or derivatives | 3 | 6.4 | 1.6 | 4.8 |
| Amphetamine or derivatives | 3 | 6.4 | 2.8 | 3.6 |
| Imidazole | 3 | 6.4 | 4.0 | 2.3 |
| N-substituted imidazole | 3 | 6.4 | 3.2 | 3.2 |
| Benzoic acid | 3 | 6.4 | 1.3 | 5.1 |
| Benzimidazole | 3 | 6.4 | 0.9 | 5.5 |
| Aromatic heteromonocyclic compound | 3 | 6.4 | 14.3 | 7.9 |
| Ketone | 3 | 6.4 | 11.9 | 5.5 |
| Aromatic homopolycyclic compound | 3 | 6.4 | 2.3 | 4.0 |
| Aralkylamine | 3 | 6.4 | 10.5 | 4.1 |
| Aromatic homomonocyclic compound | 3 | 6.4 | 9.6 | 3.2 |
| Hydroxyindole | 3 | 6.4 | 0.6 | 5.8 |
| N-acylserotonin | 3 | 6.4 | 0.4 | 6.0 |
| Indole or derivatives | 3 | 6.4 | 5.0 | 1.4 |
| Vinylogous acid | 2 | 4.3 | 5.4 | 1.1 |
| 4p-methoxyflavonoid-skeleton | 2 | 4.3 | 0.5 | 3.8 |
| N-acyl-piperidine | 2 | 4.3 | 3.4 | 0.8 |
| 7-o-methylisoflavone | 2 | 4.3 | 0.1 | 4.2 |
| Organohalogen compound | 2 | 4.3 | 14.1 | 9.8 |
| Organochloride | 2 | 4.3 | 8.7 | 4.4 |
| Aryl ketone | 2 | 4.3 | 4.6 | 0.3 |
| Naphthalene | 2 | 4.3 | 1.9 | 2.3 |
| Styrene | 2 | 4.3 | 1.8 | 2.5 |
| Tertiary amine | 2 | 4.3 | 14.6 | 10.3 |
| Tertiary aliphatic amine | 2 | 4.3 | 13.7 | 9.5 |
| Organic salt | 1 | 2.1 | 0.7 | 1.4 |
| Phosphoric acid ester | 1 | 2.1 | 0.6 | 1.5 |
| Fatty acid ester | 1 | 2.1 | 2.5 | 0.4 |
| Carboxylic acid ester | 1 | 2.1 | 13.9 | 11.8 |
| Phosphocholine | 1 | 2.1 | 0.1 | 2.0 |
| Tetraalkylammonium salt | 1 | 2.1 | 0.3 | 1.8 |
| Dialkyl phosphate | 1 | 2.1 | 0.5 | 1.7 |
| Organic phosphoric acid derivative | 1 | 2.1 | 0.8 | 1.3 |
| Fatty acyl | 1 | 2.1 | 5.9 | 3.8 |
| Organic cation | 1 | 2.1 | 0.6 | 1.6 |
| Quaternary ammonium salt | 1 | 2.1 | 0.4 | 1.7 |
| Alkyl phosphate | 1 | 2.1 | 0.6 | 1.5 |
| Aliphatic acyclic compound | 1 | 2.1 | 1.9 | 0.2 |
| 1-acyl-sn-glycero-3-phosphocholine | 1 | 2.1 | 0.1 | 2.1 |
| 5-hydroxyflavonoid | 1 | 2.1 | 1.6 | 0.5 |
| Lactam | 1 | 2.1 | 10.3 | 8.2 |
| Pyrimidone | 1 | 2.1 | 2.1 | 0.0 |
| Hydroxypyrimidine | 1 | 2.1 | 0.4 | 1.8 |
| Monohydroxyflavonoid | 1 | 2.1 | 0.0 | 2.1 |
| 4'-hydroxyflavonoid | 1 | 2.1 | 1.2 | 0.9 |
| Piperidinecarboxamide | 1 | 2.1 | 2.0 | 0.1 |
| Primary carboxylic acid amide | 1 | 2.1 | 1.3 | 0.8 |
| Halobenzene | 1 | 2.1 | 6.1 | 4.0 |
| Aryl chloride | 1 | 2.1 | 7.2 | 5.1 |
| Chlorobenzene | 1 | 2.1 | 4.2 | 2.0 |
| Aryl halide | 1 | 2.1 | 10.8 | 8.7 |
| 5-methoxyflavonoid-skeleton | 1 | 2.1 | 0.2 | 1.9 |
| Vinylogous ester | 1 | 2.1 | 1.7 | 0.4 |
| 7-methoxyflavonoid-skeleton | 1 | 2.1 | 0.4 | 1.7 |
| 7-hydroxyflavonoid | 1 | 2.1 | 1.4 | 0.7 |
| Piperidinecarboxylic acid | 1 | 2.1 | 1.2 | 0.9 |
| 3-hydroxyflavone | 1 | 2.1 | 0.2 | 1.9 |
| 3-hydroxyflavonoid | 1 | 2.1 | 0.4 | 1.7 |
| Alkyl halide | 1 | 2.1 | 3.3 | 1.2 |
| Pyrazole | 1 | 2.1 | 0.4 | 1.7 |
| Xylene | 1 | 2.1 | 0.8 | 1.3 |
| Alkyl chloride | 1 | 2.1 | 1.2 | 0.9 |
| Chloroacetamide | 1 | 2.1 | 0.1 | 2.0 |
| M-xylene | 1 | 2.1 | 0.7 | 1.4 |
| Anilide | 1 | 2.1 | 1.6 | 0.5 |
| Isoflav-3-enone skeleton | 1 | 2.1 | 0.1 | 2.1 |
| Quinone | 1 | 2.1 | 0.5 | 1.7 |
| O-quinone | 1 | 2.1 | 0.1 | 2.1 |
| Phenanthraquinone | 1 | 2.1 | 0.0 | 2.1 |
| Hydrophenanthrene | 1 | 2.1 | 0.1 | 2.1 |
| Alpha-amino acid | 1 | 2.1 | 0.6 | 1.6 |
| C-nitro compound | 1 | 2.1 | 1.3 | 0.8 |
| Organic oxoazanium | 1 | 2.1 | 1.3 | 0.8 |
| Amino acid | 1 | 2.1 | 2.9 | 0.8 |
| Organic 1,3-dipolar compound | 1 | 2.1 | 9.9 | 7.8 |
| Propargyl-type 1,3-dipolar organic compound | 1 | 2.1 | 9.9 | 7.8 |
| Organic nitro compound | 1 | 2.1 | 1.4 | 0.8 |
| Organic zwitterion | 1 | 2.1 | 1.1 | 1.0 |
| Allyl-type 1,3-dipolar organic compound | 1 | 2.1 | 1.4 | 0.7 |
| Nitrophenol | 1 | 2.1 | 0.1 | 2.0 |
| Primary aliphatic amine | 1 | 2.1 | 2.8 | 0.7 |
| Tyrosine or derivatives | 1 | 2.1 | 0.1 | 2.0 |
| Nitroaromatic compound | 1 | 2.1 | 1.1 | 1.1 |
| Primary amine | 1 | 2.1 | 6.3 | 4.2 |
| Nitrobenzene | 1 | 2.1 | 0.7 | 1.4 |
| Stilbene | 1 | 2.1 | 0.4 | 1.7 |
| Dimethoxybenzene | 1 | 2.1 | 1.7 | 0.4 |
| M-dimethoxybenzene | 1 | 2.1 | 0.6 | 1.6 |
| Cyclohexenone | 1 | 2.1 | 2.3 | 0.2 |
| Morphinan | 1 | 2.1 | 0.1 | 2.0 |
| Phenanthrene | 1 | 2.1 | 1.0 | 1.1 |
| Benzazocine | 1 | 2.1 | 0.0 | 2.1 |
| Tetralin | 1 | 2.1 | 1.5 | 0.6 |
| Isoquinolone | 1 | 2.1 | 0.4 | 1.7 |
| Cyclic ketone | 1 | 2.1 | 5.2 | 3.1 |
| Serotonin | 1 | 2.1 | 0.1 | 2.0 |
| Anthracene | 1 | 2.1 | 0.3 | 1.8 |
| 4p-o-methylisoflavone | 1 | 2.1 | 0.2 | 2.0 |
| Glycosyl compound | 1 | 2.1 | 2.4 | 0.2 |
| Acetal | 1 | 2.1 | 4.4 | 2.3 |
| Hexose monosaccharide | 1 | 2.1 | 0.7 | 1.4 |
| Polyol | 1 | 2.1 | 4.9 | 2.7 |
| O-glycosyl compound | 1 | 2.1 | 1.7 | 0.4 |
| Stilbene glycoside | 1 | 2.1 | 0.0 | 2.1 |
| Monosaccharide | 1 | 2.1 | 2.8 | 0.7 |
| Oxane | 1 | 2.1 | 3.4 | 1.3 |
| Phenolic glycoside | 1 | 2.1 | 0.6 | 1.5 |
| Primary alcohol | 1 | 2.1 | 5.5 | 3.4 |
| Secondary aliphatic amine | 1 | 2.1 | 4.4 | 2.2 |
| Secondary amine | 1 | 2.1 | 5.3 | 3.1 |
| 1,2-aminoalcohol | 1 | 2.1 | 3.3 | 1.2 |
| Hydroxyisoflavonoid | 1 | 2.1 | 0.2 | 1.9 |
| Pyranoisoflavonoid | 1 | 2.1 | 0.1 | 2.0 |
| 2,2-dimethyl-1-benzopyran | 1 | 2.1 | 1.5 | 0.6 |
| Amino acid or derivatives | 1 | 2.1 | 10.7 | 8.6 |
| Piperazine | 1 | 2.1 | 2.9 | 0.7 |
| 1,4-diazinane | 1 | 2.1 | 2.9 | 0.7 |
| Diphenylmethane | 1 | 2.1 | 2.1 | 0.1 |
| Benzamide | 1 | 2.1 | 1.8 | 0.4 |
| N-alkylpiperazine | 1 | 2.1 | 3.1 | 1.0 |
| 7-hydroxycoumarin | 1 | 2.1 | 0.2 | 1.9 |
Two bar plots will appear below this message. The first shows the proportion of the total intensity of these features explained by this Mass2Motif. Red bars show the total intensity (across the whole dataset), blue bars show the proportion explained by the selected Mass2Motif. The second shows the number of times each feature in this Mass2Motif appears in the documents associated with this Mass2Motif.
The following table lists all fragmentation spectra that are explained by this Mass2Motif at the threshold specified in the experiment option.
| Fragmentation spectra | Precursor Mass | Parent mass | Annotation | Probability | Overlap Score |
|---|---|---|---|---|---|
| CCMSLIB00000579766.ms | 223.0754 | 223.0754 | Flavone M+H | 1.000 | 0.018 |
| CCMSLIB00000479320.ms | 522.3554 | 522.3554 | 1,2-Dierucoyl-sn-glycero-3-phosphocholine M+H | 0.948 | 0.002 |
| CCMSLIB00000079818.ms | 239.0703 | 239.0703 | MLS002639146-01!5-hydroxy-2-phenylchromen-4-one M+H | 0.814 | 0.311 |
| CCMSLIB00000078635.ms | 415.1322 | 415.1322 | Nafcillin Sodium [M+H] | 0.546 | 0.025 |
| CCMSLIB00000579760.ms | 235.1441 | 235.1441 | 0348_Lenacil M+H | 0.474 | 0.021 |
| CCMSLIB00000085356.ms | 281.1172 | 281.1172 | MLS001146879-01!35212-22-7 M+H | 0.456 | 0.398 |
| CCMSLIB00000079859.ms | 239.0703 | 239.0703 | MLS001049036-01!2-(4-hydroxyphenyl)chromen-4-one M+H | 0.454 | 0.309 |
| CCMSLIB00000078937.ms | 281.1172 | 281.1172 | 35212-22-7 [M+H] | 0.436 | 0.305 |
| CCMSLIB00000080246.ms | 253.0859 | 253.0859 | MLS000863607-01! M+H | 0.416 | 0.060 |
| CCMSLIB00000079606.ms | 436.1755 | 436.1755 | MLS001140969-01!4-[[[2-(2-oxo-4-phenylchromen-7-yl)oxyacetyl]amino]methyl]cyclohexane-1-carboxylic acid M+H | 0.399 | 0.324 |
| CCMSLIB00000080397.ms | 223.0754 | 223.0754 | MLS002177804-01! M+H | 0.373 | 0.037 |
| CCMSLIB00000080285.ms | 395.1601 | 395.1601 | MLS001140565-01!1-[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxyacetyl]piperidine-4-carboxamide M+H | 0.372 | 0.403 |
| CCMSLIB00000080189.ms | 239.0703 | 239.0703 | MLS002695239-01!7-hydroxy-2-phenylchromen-4-one M+H | 0.367 | 0.230 |
| CCMSLIB00000079475.ms | 432.1442 | 432.1442 | MLS001159064-01!(2S)-2-[[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxyacetyl]amino]-3-phenylpropanoic acid M+H | 0.351 | 0.172 |
| CCMSLIB00000079146.ms | 515.2442 | 515.2442 | Telmisartan aka 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid M+H | 0.329 | 0.052 |
| CCMSLIB00000079860.ms | 253.0859 | 253.0859 | MLS001049012-01!7-methoxy-3-phenylchromen-4-one M+H | 0.319 | 0.221 |
| CCMSLIB00000080069.ms | 466.1052 | 466.1052 | MLS001159063-01!3-(4-chlorophenyl)-2-[[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxyacetyl]amino]propanoic acid M+H | 0.313 | 0.354 |
| CCMSLIB00000079852.ms | 283.0965 | 283.0965 | MLS001049094-01! M+H | 0.275 | 0.299 |
| CCMSLIB00000080552.ms | 424.1755 | 424.1755 | MLS001157807-01!4-[[2-(6-oxobenzo[c]chromen-3-yl)oxypropanoylamino]methyl]cyclohexane-1-carboxylic acid M+H | 0.257 | 0.308 |
| CCMSLIB00000080254.ms | 269.0808 | 269.0808 | MLS002707301-01!7-hydroxy-2-(4-methoxyphenyl)chromen-4-one M+H | 0.234 | 0.021 |
| CCMSLIB00000079456.ms | 239.0703 | 239.0703 | MLS001049140-01!7-hydroxy-3-phenylchromen-4-one M+H | 0.213 | 0.228 |
| CCMSLIB00000080368.ms | 396.1442 | 396.1442 | MLS001141237-01!1-[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxyacetyl]piperidine-4-carboxylic acid M+H | 0.210 | 0.243 |
| CCMSLIB00000079401.ms | 239.0703 | 239.0703 | MLS002207277-01!3-hydroxy-2-phenylchromen-4-one M+H | 0.184 | 0.209 |
| CCMSLIB00000579689.ms | 278.1055 | 278.1055 | Metazachlor M+H | 0.160 | 0.036 |
| CCMSLIB00000079687.ms | 436.1755 | 436.1755 | MLS001140958-01!4-[[[2-(2-oxo-3-phenylchromen-7-yl)oxyacetyl]amino]methyl]cyclohexane-1-carboxylic acid M+H | 0.141 | 0.160 |
| CCMSLIB00000085760.ms | 209.0597 | 209.0597 | MLS000571180-01!Phenanthraquinone M+H | 0.127 | 0.107 |
| CCMSLIB00000579703.ms | 227.0662 | 227.0662 | 3-nitrotyrosine M+H | 0.122 | 0.085 |
| CCMSLIB00000080169.ms | 257.1172 | 257.1172 | "MLS000863581-01!4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]phenol" M+H | 0.111 | 0.304 |
| CCMSLIB00000085494.ms | 330.1700 | 330.1700 | MLS002207021-01!Sinomenine115-53-7 M+H | 0.108 | 0.512 |
| CCMSLIB00000080448.ms | 499.1500 | 499.1500 | MLS001140964-01!(2S)-3-(5-hydroxy-1H-indol-3-yl)-2-[[2-(2-oxo-4-phenylchromen-7-yl)oxyacetyl]amino]propanoic acid M+H | 0.103 | 0.306 |
| CCMSLIB00000579754.ms | 195.0804 | 195.0804 | Anthrone M+H | 0.101 | 0.011 |
| CCMSLIB00000079486.ms | 267.1380 | 267.1380 | MLS001048917-01!2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol M+H | 0.096 | 0.221 |
| CCMSLIB00000079367.ms | 438.1911 | 438.1911 | MLS001140981-01!4-[[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxypropanoylamino]methyl]cyclohexane-1-carboxylic acid M+H | 0.096 | 0.163 |
| CCMSLIB00000080391.ms | 483.1551 | 483.1551 | MLS001075310-01!(2R)-3-(1H-indol-3-yl)-2-[[2-(2-oxo-4-phenylchromen-7-yl)oxyacetyl]amino]propanoic acid M+H | 0.092 | 0.287 |
| CCMSLIB00000080300.ms | 283.0965 | 283.0965 | MLS002695973-01! M+H | 0.085 | 0.440 |
| CCMSLIB00000079427.ms | 501.1656 | 501.1656 | MLS001157908-01!3-(5-hydroxy-1H-indol-3-yl)-2-[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxypropanoylamino]propanoic acid M+H | 0.080 | 0.115 |
| CCMSLIB00000085639.ms | 443.1449 | 443.1449 | MLS002222335-01!3963-95-9 M+H | 0.073 | 0.302 |
| CCMSLIB00000085693.ms | 405.1544 | 405.1544 | MLS002207168-01!Deoxyrhapontin from rhubarb root30197-14-9 M+H | 0.067 | 0.173 |
| CCMSLIB00000078648.ms | 260.1645 | 260.1645 | Propranolol HCl [M+H] | 0.065 | 0.042 |
| CCMSLIB00000080538.ms | 353.1020 | 353.1020 | MLS000697602-01! M+H | 0.064 | 0.091 |
| CCMSLIB00000579783.ms | 515.2442 | 515.2442 | Telmisartan M+H | 0.062 | 0.067 |
| CCMSLIB00000080584.ms | 531.1762 | 531.1762 | MLS001140855-01!(2S)-3-(5-hydroxy-1H-indol-3-yl)-2-[2-(8-methoxy-4-methyl-6-oxobenzo[c]chromen-3-yl)oxypropanoylamino]propanoic acid M+H | 0.061 | 0.271 |
| CCMSLIB00000080177.ms | 497.1707 | 497.1707 | MLS001141003-01!(2R)-3-(1H-indol-3-yl)-2-[2-(2-oxo-4-phenylchromen-7-yl)oxypropanoylamino]propanoic acid M+H | 0.061 | 0.266 |
| CCMSLIB00000085438.ms | 450.3115 | 450.3115 | MLS002153330-01!SNC80156727-74-1 M+H | 0.061 | 0.132 |
| CCMSLIB00000079564.ms | 283.0965 | 283.0965 | "MLS001049018-01!5,7-dimethoxy-4-phenylchromen-2-one" M+H | 0.059 | 0.311 |
| CCMSLIB00000005935.ms | 515.2442 | 515.2442 | Telmisartan M+H | 0.055 | 0.052 |
| CCMSLIB00000078780.ms | 307.0601 | 307.0601 | "NCGC00160336-01!7'-Hydroxy-[3,4']bichromenyl-2,2'-dione" M+H | 0.051 | 0.441 |
The fragmentation spectra of molecules explained by this Mass2Motif are plotted below. Features (fragments and losses) explained by this Mass2Motif will be coloured red, while parent ion is coloured in blue. Click Next and Previous to cycle through the fragmentation spectra.